Elörehaladott perifériás artériás érbetegségben szenvedok kezelése autológ csontveloi, vagy periférias vérbol származó ossejtekkel

Translated title of the contribution: Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral ischaemia

Z. Boda, Zoltán Veréb, Éva Rajnavolgji

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

No effective medical therapies have been developed sofar to enhance blood flow in the legs of patients with peripheral arterial disease (PAD). For patients with limb threatening ischaemia the only option for relief of rest pain or gangraena is amputation. There is evidence in experimental and clinical studies that adult bone marrow-derived stem cells and endothelial progenitor cells participate in the development of new blood vessels, called neoangiogenesis or neovascularization. Clinical results induced by autologous bone marrow stem cells or angiogenic growth/differentiation factors in end-stage patients with PAD are summarized. Considering the relatively few number of patients treated by angiogenic therapy, the interpretation of clinical results needs cautiousness.

Original languageHungarian
Pages (from-to)1155-1160
Number of pages6
JournalOrvosi Hetilap
Volume147
Issue number25
Publication statusPublished - Jun 25 2006

Fingerprint

Cell- and Tissue-Based Therapy
Bone Marrow Cells
Blood Cells
Stem Cells
Ischemia
Peripheral Arterial Disease
Growth Differentiation Factors
Amputation
Blood Vessels
Leg
Extremities
Bone Marrow
Pain
Endothelial Progenitor Cells
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Elörehaladott perifériás artériás érbetegségben szenvedok kezelése autológ csontveloi, vagy periférias vérbol származó ossejtekkel. / Boda, Z.; Veréb, Zoltán; Rajnavolgji, Éva.

In: Orvosi Hetilap, Vol. 147, No. 25, 25.06.2006, p. 1155-1160.

Research output: Contribution to journalArticle

@article{d26ebe86f3e64ae1878fdacbdc8da993,
title = "El{\"o}rehaladott perif{\'e}ri{\'a}s art{\'e}ri{\'a}s {\'e}rbetegs{\'e}gben szenvedok kezel{\'e}se autol{\'o}g csontveloi, vagy perif{\'e}rias v{\'e}rbol sz{\'a}rmaz{\'o} ossejtekkel",
abstract = "No effective medical therapies have been developed sofar to enhance blood flow in the legs of patients with peripheral arterial disease (PAD). For patients with limb threatening ischaemia the only option for relief of rest pain or gangraena is amputation. There is evidence in experimental and clinical studies that adult bone marrow-derived stem cells and endothelial progenitor cells participate in the development of new blood vessels, called neoangiogenesis or neovascularization. Clinical results induced by autologous bone marrow stem cells or angiogenic growth/differentiation factors in end-stage patients with PAD are summarized. Considering the relatively few number of patients treated by angiogenic therapy, the interpretation of clinical results needs cautiousness.",
keywords = "Angiogenic growth/differentiation factor, Autologous stem-cell therapy, Endothelial progenitor cell, Peripheral arterial disorder",
author = "Z. Boda and Zolt{\'a}n Ver{\'e}b and {\'E}va Rajnavolgji",
year = "2006",
month = "6",
day = "25",
language = "Hungarian",
volume = "147",
pages = "1155--1160",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "25",

}

TY - JOUR

T1 - Elörehaladott perifériás artériás érbetegségben szenvedok kezelése autológ csontveloi, vagy periférias vérbol származó ossejtekkel

AU - Boda, Z.

AU - Veréb, Zoltán

AU - Rajnavolgji, Éva

PY - 2006/6/25

Y1 - 2006/6/25

N2 - No effective medical therapies have been developed sofar to enhance blood flow in the legs of patients with peripheral arterial disease (PAD). For patients with limb threatening ischaemia the only option for relief of rest pain or gangraena is amputation. There is evidence in experimental and clinical studies that adult bone marrow-derived stem cells and endothelial progenitor cells participate in the development of new blood vessels, called neoangiogenesis or neovascularization. Clinical results induced by autologous bone marrow stem cells or angiogenic growth/differentiation factors in end-stage patients with PAD are summarized. Considering the relatively few number of patients treated by angiogenic therapy, the interpretation of clinical results needs cautiousness.

AB - No effective medical therapies have been developed sofar to enhance blood flow in the legs of patients with peripheral arterial disease (PAD). For patients with limb threatening ischaemia the only option for relief of rest pain or gangraena is amputation. There is evidence in experimental and clinical studies that adult bone marrow-derived stem cells and endothelial progenitor cells participate in the development of new blood vessels, called neoangiogenesis or neovascularization. Clinical results induced by autologous bone marrow stem cells or angiogenic growth/differentiation factors in end-stage patients with PAD are summarized. Considering the relatively few number of patients treated by angiogenic therapy, the interpretation of clinical results needs cautiousness.

KW - Angiogenic growth/differentiation factor

KW - Autologous stem-cell therapy

KW - Endothelial progenitor cell

KW - Peripheral arterial disorder

UR - http://www.scopus.com/inward/record.url?scp=33748757546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748757546&partnerID=8YFLogxK

M3 - Article

C2 - 16893130

AN - SCOPUS:33748757546

VL - 147

SP - 1155

EP - 1160

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 25

ER -